Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwarzenberger, P
Right arrow Articles by Keller, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarzenberger, P
Right arrow Articles by Keller, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor

P Schwarzenberger, SE Spence, JM Gooya, D Michiel, DT Curiel, FW Ruscetti and JR Keller

Laboratory of Leukocyte Biology, SAIC-Frederick, MD, USA.

In this report, we describe a novel gene therapy approach for hematopoietic stem/progenitor cells using a specific receptor-mediated gene transfection procedure to target c-kit+ cell lines. The vector consists of plasmid DNA containing a luciferase reporter gene that is condensed by electrostatic forces with polylysine (PL) covalently linked to streptavidin (binds biotinylated ligand) and PL covalently linked to adenovirus (AD; to achieve endosomal lysis) with the final addition of biotinylated steel factor (SLF-biotin). Targeted transfection of growth factor-dependent hematopoietic progenitor cell lines that express c-kit showed specific luciferase gene expression over cell lines that did not express c-kit. This effect was dependent on the dose of SLF-biotin and was competed by excess SLF or with monoclonal antibodies that recognize c-kit and block the binding of SLF to its receptor. Maximum transfection efficiency (> 90%) requires a 2- hour incubation period of the vector with the cells, and maximum gene expression occurred 30 hours later. Removal of the endosomalytic agent, AD, from the vector resulted in the loss of gene expression. Vector targeting was versatile and could be changed by the addition of other biotinylated ligands. In principle, this vector should be broadly applicable to deliver genes to hematopoietic stem/progenitor cells in vitro and in vivo.

Volume 87, Issue 2, pp. 472-478, 01/15/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
E. J. Lee and J L. Jameson
Gene therapy of pituitary diseases
J. Endocrinol., June 1, 2005; 185(3): 353 - 362.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. Murphy, B. Gottgens, A. Vegiopoulos, M.-J. Sanchez, A. D. Leavitt, S. P. Watson, A. R. Green, and J. Frampton
Manipulation of Mouse Hematopoietic Progenitors by Specific Retroviral Infection
J. Biol. Chem., October 31, 2003; 278(44): 43556 - 43563.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Q. Zhong, P. Oliver, W. Huang, D. Good, V. La Russa, Z. Zhang, J. R. Cork, R. W. Veith, C. Theodossiou, J. K. Kolls, et al.
Efficient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem Cells
J. Virol., November 1, 2001; 75(21): 10393 - 10400.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Smith, J. R. Keller, N. C. Lohrey, C. S. McCauslin, M. Ortiz, K. Cowan, and S. E. Spence
Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens
PNAS, August 3, 1999; 96(16): 8855 - 8860.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Youssoufian, F. A.E. Kruyt, and X. Li
Protein Replacement by Receptor-Mediated Endocytosis Corrects the Sensitivity of Fanconi Anemia Group C Cells to Mitomycin C
Blood, January 1, 1999; 93(1): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. K. Fielding, M. Maurice, F. J. Morling, F.-L. Cosset, and S. J. Russell
Inverse Targeting of Retroviral Vectors: Selective Gene Transfer in a Mixed Population of Hematopoietic and Nonhematopoietic Cells
Blood, March 1, 1998; 91(5): 1802 - 1809.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood, February 15, 1998; 91(4): 1101 - 1134.
[Full Text] [PDF]


Home page
BloodHome page
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood, August 15, 1997; 90(4): 1345 - 1364.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Zhong, J. K. Kolls, and P. Schwarzenberger
Retrovirus Molecular Conjugates. A NOVEL, HIGH TRANSDUCTION EFFICIENCY, POTENTIALLY SAFETY-IMPROVED, GENE TRANSFER SYSTEM
J. Biol. Chem., June 29, 2001; 276(27): 24601 - 24607.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020